The reason some people fail to recover their sense of smell after COVID-19 is linked to an ongoing immune assault on olfactory nerve cells and an associated decline in the number of those cells, a team of scientists led by Duke Health report.

Following the recent organizational changes at Twitter and concerns about how they may affect the platform, DCRI Chief Science & Digital Officer Eric Perakslis, PhD, offers insights for clinicians and researchers who use the platform to share their work.

Nadine Barrett, PhD, and Brian Southwell, PhD, have been appointed to serve on a National Academy of Science, Engineering and Math (NASEM) committee on Understanding and Addressing Misinformation about Science. 

Students from Duke’s Health Data Science (HDS) and AI Health Data Science Fellowship presented their work at the 2022 Duke AI Health Poster Showcase on Dec. 6.

Duke alum Leslie Graves has known about Duke’s mission to provide life-changing cancer care since she was a teenager. In October 2022, Graves received the William W. Shingleton Award, the highest honor given to friends of Duke Cancer Institute.

EDI Spotlight shines on Julius Wilder, MD, PhD, a gastroenterologist and hepatologist and Chair of the Department of Medicine’s Diversity, Equity, Inclusion, and Antiracism committee (DEIAR).

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.

A large study of military members led by researchers at Duke Health and the Durham VA identified four genes that are linked to an increased risk of suicidal thoughts and behaviors.

New research from Padma Gulur, MD, a professor of anesthesiolgy at Duke University Medical Center bolstered a bright idea about pain management: green light exposure that may help the 20% of adults who have chronic pain.

Testing for procalcitonin, a blood biomarker that is increased in people with a bacterial infection, could help physicians more quickly and effectively determine whether patients need antibiotics. Knowing that would ultimately reduce the rate of unnecessary antibiotic use, according to a new study from Duke Health and four other U.S. sites.